register free | resend password


Hutchison China Meditech Limited: Blocklisting Six Monthly Return

ID: 1477909
recent pressrelease next pressrelease

(businesspress24) - HONG KONG, CHINA -- (Marketwired) -- 12/29/16 -- Hutchison China Meditech Limited (NASDAQ: HCM) (AIM: HCM)

: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) announces the following blocklisting six monthly return:

Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 0001). For more information, please visit: .

Contacts:
RNS
Customer
Services
0044-207797-4400



More information:
http://www.mss-software.com http://primerealtyinc.com/ http://www.writingaliteraturereview.com http://www.writingabio.com/ http://www.floormat.com http://www.detallescomunion.com/ http://www.writemythesis.net



Keywords (optional):

hutchison-china-meditech-limited,



Company information / Profile:

PressRelease by

Requests:



PressContact / Agency:



published by: Marketwired
print pressrelease  send to a friend  

Date: 12/29/2016 - 08:22
Language: English
News-ID 1477909
Character count: 3119
Kontakt-Informationen:
Firma: Hutchison China Meditech Limited
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: HONG KONG, CHINA
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 193

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 406
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 64


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.